(Q44643399)

English

Alterations in cholinergic and non‐cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β‐amyloid plaque pathology

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology (English)

1 reference

Europe PubMed Central

5 December 2017

Alterations in cholinergic and non‐cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with β‐amyloid plaque pathology (English)

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

0 references

neurotransmitter

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599482

28 March 2024

author name string

Margrit Klingner

1

1 reference

Europe PubMed Central

5 December 2017

Jenny Apelt

2

1 reference

Europe PubMed Central

5 December 2017

Ashok Kumar

3

1 reference

Europe PubMed Central

5 December 2017

Dietlind Sorger

4

1 reference

Europe PubMed Central

5 December 2017

Osama Sabri

5

1 reference

Europe PubMed Central

5 December 2017

Jörg Steinbach

6

1 reference

Europe PubMed Central

5 December 2017

Matthias Scheunemann

7

1 reference

Europe PubMed Central

5 December 2017

Reinhard Schliebs

8

1 reference

Europe PubMed Central

5 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2003

1 reference

Europe PubMed Central

5 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0736574803001072?httpAccept=text/xml

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

https://api.elsevier.com/content/article/PII:S0736574803001072?httpAccept=text/plain

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.ijdevneu.2003.08.001

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.ijdevneu.2003.08.001

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

https://onlinelibrary.wiley.com/doi/full-xml/10.1016/j.ijdevneu.2003.08.001

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

International Journal of Developmental Neuroscience

1 reference

Europe PubMed Central

5 December 2017

21

1 reference

Europe PubMed Central

5 December 2017

7

1 reference

Europe PubMed Central

5 December 2017

357-369

1 reference

Europe PubMed Central

5 December 2017

Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology

1

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein.

2

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Beta-amyloid peptides as direct cholinergic neuromodulators: a missing link?

3

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

4

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The cholinergic hypothesis of geriatric memory dysfunction

5

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.

6

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Impaired acquisition of novel locomotor tasks in aged and norepinephrine-depleted F344 rats

7

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

8

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The cholinergic neuronal phenotype in alzheimer′s disease

10

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein

11

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus.

12

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The effect of cholinergic, GABAergic, serotonergic, and glutamatergic receptor modulation on posttrial memory processing in the hippocampus.

13

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein.

14

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Stable beta-secretase activity and presynaptic cholinergic markers during progressive central nervous system amyloidogenesis in Tg2576 mice

16

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Cholinergic neuropathology in a mouse model of Alzheimer's disease

17

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

18

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha 2- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals

19

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

20

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.

22

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Adrenergic receptors in aging and Alzheimer's disease: Decreased α2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex

23

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus

24

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices.

25

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

26

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons.

27

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Plasticity of neuronal receptors

28

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice.

29

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Neuroreceptor changes in Alzheimer disease

30

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease

31

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.

32

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias

33

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus

34

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Adaptive Changes of Neurotransmitter Receptor Mechanisms in the Central Nervous System

35

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Changes in beta-adrenergic receptor subtypes in Alzheimer-type dementia.

36

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

37

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Repeated administration of tacrine to normal rats: effects on cholinergic, glutamatergic, and GABAergic receptor subtypes in rat brain using receptor autoradiography.

38

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system

39

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour

40

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant

41

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Impaired neurotransmitter systems by Abeta amyloidosis in APPsw transgenic mice overexpressing amyloid beta protein precursor.

42

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

43

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors

44

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

45

1 reference

10.1016/J.IJDEVNEU.2003.08.001

https://api.crossref.org/works/10.1016/J.IJDEVNEU.2003.08.001

28 March 2024

Identifiers

10.1016/J.IJDEVNEU.2003.08.001

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44643399&oldid=2115069352"